Juan Abonia

Professor

Cincinnati Children's Hospital Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Juan Abonia is a Professor at Cincinnati Children's Hospital Medical Center in the United States. His research focuses on eosinophilic gastrointestinal disorders, with notable contributions to understanding treatment strategies and the underlying pathophysiology. He has published recent articles exploring various dietary interventions, inflammation reduction, and the development of consensus recommendations in this field.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Eileen Alexander

Associate Professor, Tenured

Xavier University of Louisiana

UNITED STATES

View details

margaret collins

University of Cincinnati College of Medicine

UNITED STATES

View details

Melanie Ruffner

Assistant Professor

University of Pennsylvania

UNITED STATES

View details

Matthew Giannetti

Harvard University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Juan Abonia

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial

Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis

Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting

Mast cell activation syndrome: Current understanding and research needs

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers’ journey

One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial

International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.

Acquired Esophageal Strictures in Children: Morphometric and Immunohistochemical Analyses

Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

Collaborators (4)

Eileen Alexander

margaret collins

Melanie Ruffner

Matthew Giannetti

Make your next move.

Juan Abonia

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial

Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis

Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma &amp; Immunology meeting

Mast cell activation syndrome: Current understanding and research needs

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers’ journey

One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial

International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature.

Acquired Esophageal Strictures in Children: Morphometric and Immunohistochemical Analyses

Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study

Collaborators (4)

Eileen Alexander

margaret collins

Melanie Ruffner

Matthew Giannetti

Make your next move.

Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting